191 related articles for article (PubMed ID: 8257144)
1. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.
Israel D; Gillum JG; Turik M; Harvey K; Ford J; Dalton H; Towle M; Echols R; Heller AH; Polk R
Antimicrob Agents Chemother; 1993 Oct; 37(10):2193-9. PubMed ID: 8257144
[TBL] [Abstract][Full Text] [Related]
2. Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.
Echols R; Weinstein MP; O'Keeffe B; Shah A; Heller AH
J Antimicrob Chemother; 1994 Jan; 33(1):111-8. PubMed ID: 8157551
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar.
Hyatt JM; Nix DE; Schentag JJ
Antimicrob Agents Chemother; 1994 Dec; 38(12):2730-7. PubMed ID: 7695254
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.
Lister PD; Sanders CC
Antimicrob Agents Chemother; 1999 May; 43(5):1118-23. PubMed ID: 10223923
[TBL] [Abstract][Full Text] [Related]
6. Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
Machka K; Milatovic D
Eur J Clin Microbiol; 1987 Feb; 6(1):59-62. PubMed ID: 3106034
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion.
Burgess DS; Hastings RW; Hardin TC
Clin Ther; 2000 Jan; 22(1):66-75. PubMed ID: 10688391
[TBL] [Abstract][Full Text] [Related]
8. In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.
Hyatt JM; Nix DE; Stratton CW; Schentag JJ
Antimicrob Agents Chemother; 1995 Aug; 39(8):1711-6. PubMed ID: 7486906
[TBL] [Abstract][Full Text] [Related]
9. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
Well M; Naber KG; Kinzig-Schippers M; Sörgel F
Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
Zeiler HJ; Beermann D; Wingender W; Förster D; Schacht P
Infection; 1988; 16 Suppl 1():S19-23. PubMed ID: 3286510
[TBL] [Abstract][Full Text] [Related]
11. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
[TBL] [Abstract][Full Text] [Related]
12. Urinary pharmacodynamics of low-dose ciprofloxacin and ofloxacin.
Stein GE; Schooley S; McMillan J
Diagn Microbiol Infect Dis; 1998 Apr; 30(4):261-5. PubMed ID: 9582586
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.
Paradis D; Vallée F; Allard S; Bisson C; Daviau N; Drapeau C; Auger F; LeBel M
Antimicrob Agents Chemother; 1992 Oct; 36(10):2085-92. PubMed ID: 1444289
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.
Lagast H; Husson M; Klastersky J
J Antimicrob Chemother; 1985 Sep; 16(3):341-7. PubMed ID: 2932416
[TBL] [Abstract][Full Text] [Related]
15. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
17. Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.
Dan M; Poch F; Quassem C; Kitzes R
Antimicrob Agents Chemother; 1994 Apr; 38(4):837-41. PubMed ID: 8031055
[TBL] [Abstract][Full Text] [Related]
18. Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.
Nicolau DP; Nightingale CH; Banevicius MA; Fu Q; Quintiliani R
Antimicrob Agents Chemother; 1996 Jan; 40(1):61-4. PubMed ID: 8787880
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
20. A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa.
Madaras-Kelly KJ; Larsson AJ; Rotschafer JC
J Antimicrob Chemother; 1996 Apr; 37(4):703-10. PubMed ID: 8722536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
